With a PhD in Molecular Microbiology and an MBA, Patrick brings over 15 years of expertise in microbiome science, AI-driven biopharma, and biotech commercialization. He has held executive roles in longevity-focused startups and pharma (Sanofi), and trained at MIT. Patrick now leads Trilliome’s mission to advance precision prebiotics for healthy aging and inflammation modulation through science-backed, sustainable innovation.